NCT02339948View on ClinicalTrials.gov

Phase II Trial of SBRT + or - IMRT in Treatment of Patients With Clinically Confined Prostate Adenocarcinoma

NACompletedINTERVENTIONAL
Enrollment

279

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

October 31, 2019

Study Completion Date

October 31, 2019

Conditions
Prostate Adenocarcinoma
Interventions
RADIATION

SBRT

8.0 Gy per fraction for 5 fractions for a total of 40 Gy

Trial Locations (4)

29577

Century Oncology, Myrtle Beach

33324

21st Century Oncology, Plantation

33907

21st Century Oncology, Fort Myers

48334

21st Century Oncology, Farmington Hills

All Listed Sponsors
lead

GenesisCare USA

OTHER

NCT02339948 - Phase II Trial of SBRT + or - IMRT in Treatment of Patients With Clinically Confined Prostate Adenocarcinoma | Biotech Hunter | Biotech Hunter